Back to search
Neuromyelitis Optica Spectrum Disorder Attack
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neuromyelitis Optica Spectrum Disorder Attack trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Neuromyelitis Optica Spectrum Disorder Attack trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is a multicenter, prospective cohort study designed to enroll 50 NMOSD patients who receive Satralizumab treatment during the early phase of an NMOSD…
This project is a multi-center, prospective, real-world cohort study that collects clinical data of Chinese patients with AQP4-positive NMOSD in the acute stage…
The primary objective of this study is to evaluate the safety and tolerability of sivelestat sodium hydrate administered in combination with standard steroid pu…
Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing, inflammatory autoimmune disorder of the central nervous system characterized by the pathogenic an…